CytoMed Therapeutics Ltd (GDTC) Financial Statements
CytoMed Therapeutics Ltd (GDTC) files with the U.S. Securities and Exchange Commission under CIK 0001873093. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- 324.39 thousand SGD
- Net Income
- -4.00 million SGD
- Total Assets
- 7.98 million SGD
- Net Cash from Operations
- -3.70 million SGD
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Mar 31, 2026. Source: SEC filings (EDGAR XBRL). Amounts in SGD.
Open the full financial statements for GDTC in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History